J&J booster 85% effective against Omicron - South Africa study

  • 📰 gmanews
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 68%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

A booster of US coronavirus vaccine Johnson & Johnson was 85 percent effective in preventing serious illness in areas where Omicron was dominant, a South African trial study indicated Thursday.

The South African Medical Research Council conducted the study on health workers from November 15 to December 20, but it has still not been peer-reviewed.

The South African Medical Research Council conducted the study on health workers from November 15 to December 20, but it has still not been peer-reviewed. "Data from the... study confirm that the Johnson & Johnson COVID-19 booster shot provides 85 percent effectiveness against hospitalization in areas where Omicron is dominant," Johnson & Johnson said.

Around half a million South African health staff have received Johnson jabs as part of clinical trials.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Dont believe a fake news & big lie!

Give these to all government leaders to test it out then report back to us the outcome.

When will this insane propaganda scam end? Scamdemic

And South Africa also said that Omicron is mild, as far as data shows. So ... Baka pwede relax muna tayo

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 11. in LAW

Law Law Latest News, Law Law Headlines